Comparison of Vascular Catheter-Related Thrombosis and Risk Factors After Oncologic and Non-Oncologic Major Surgery
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorMersin University
About this trial
The aim of this study was to prospectively evaluate vascular catheter-related thrombosis and risk factors using daily bedside ultrasonography after oncologic and non-oncologic major surgery.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adult patient (18-80 years old)
No hematological disease causing hypercoagulability
Not receiving anticoagulant/antifibrinolytic medications at the therapy dose
The vascular structure can be visualized with US
Disqualifiers
Presence of renal failure
Pediatric patients
Presence of hematological malignancy
Inadequate US imaging
Trial design
Design model
Parallel
Treatments tested in this trial
Ultrasonographic evaluation of vascular catheter-related thrombosis after oncological surgery.
Diagnostic testIn patients who will undergo oncological surgery and have a central venous catheter, the presence of thrombosis, its duration of occurrence and its dimensions will be evaluated by ultrasonography.
Ultrasonographic evaluation of vascular catheter-related thrombosis after non-oncological surgery.
Diagnostic testIn patients who will undergo non-oncological surgery and have a central venous catheter, the presence of thrombosis, its duration of occurrence and its dimensions will be evaluated by ultrasonography.
Treatment groups
100 Participants
are divided into 2 treatment groupsGroup A: Catheter-related thrombosis in oncologic patients after major surgeryExperimental treatment 1 intervention
Group B: Catheter-related thrombosis in non-oncologic patients after major surgeryActive comparator 1 intervention
Trial outcomes
Primary outcomes
1
Incidence of catheter related vascular thrombosis after surgery
The incidence of vascular catheter-related thrombus in oncologic and non-oncologic surgery patients.
Time frame
The vascular catheter will be monitored for the duration of its stay, at least 10 days if possible.Secondary outcomes
1
Time from vascular catheter placement to the onset of thrombus formation
The time from the placement of the vascular catheter until the first detection of thrombus according to US criteria
Time frame
Daily assessment until vascular catheter removal, if possible for at least 10 days postoperatively2
Relationship between demographic characteristics of patients (age, gender and additional diseases) recorded on the preoperative anesthesia assessment form and vascular catheter-related thrombosis
Comparison of patients according to gender, age and additional diseases
Time frame
From preoperative anesthesia assessment to postoperative day 103
Daily changes in thrombus area (cm2) from the diagnosis of vascular catheter-related thrombus to catheter removal or patient discharge
Daily US evaluation of the area in patients with catheter related thrombus formation
Time frame
Daily assessment until vascular catheter removal, if possible for at least 10 days postoperatively4
The incidence of severe complications such as pulmonary embolism, cerebrovascular disease or acute coronary ischemia that may occur due to vascular catheter-related thrombosis
Evaluation for the development of pulmonary embolism, cerebrovascular occlusions and acute coronary ischemia
Time frame
Daily assessment until vascular catheter removal, if possible for at least 30 days postoperativelySponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov